Original Research
Accepted on 22 Dec 2025
Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 142 views
Type at least 3 characters
9,301 articles
articles
Systematic Review
Accepted on 22 Dec 2025
Ferroptosis and Immunity: A Bibliometric Analysis of Research Hotspots and Frontiers (2012-2025)
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Accepted on 22 Dec 2025
Unlocking Ferroptosis to Overcome Cancer Stem Cells-Mediated Treatment Failure and Immune Evasion
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Accepted on 22 Dec 2025
Iron-Fueled Ferroptosis: A New Axis for Immunomodulation to Overcome Cancer Drug Resistance—From Immune Microenvironment Crosstalk to Therapeutic Translation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 108 views
Original Research
Accepted on 22 Dec 2025
Dual function antibody targeting αvβ3 and PD-L1 provide a promising strategy for solid tumor therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 190 views
Mini Review
Accepted on 22 Dec 2025
IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 22 Dec 2025
Integrated Single-Cell and Bulk Transcriptomic Analysis Reveals Shared Pathogenesis and Prognostic Biomarkers in Breast and Thyroid Cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 106 views
Review
Accepted on 22 Dec 2025
THE BROAD SPECTRUM OF CANCER & IMMUNOTHERAPY: ACHIEVEMENTS AND LIMITATIONS
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Mini Review
Accepted on 22 Dec 2025
The Roles of the mtDNA-cGAS-STING Axis in Tumor Immunity: From Immune Activation to Immune Evasion
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 103 views
Editorial
Published on 22 Dec 2025
Editorial: Immune-checkpoint inhibitors and immunometabolic reprogramming in cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1760910
- 849 views
Original Research
Published on 22 Dec 2025
Novel pan-cancer T cell exhaustion signature forecasts immunotherapy response and unveils BCAP31 in macrophages as a therapeutic target in neuroblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1709225
- 1,143 views
Original Research
Accepted on 19 Dec 2025
SLC40A1-mediated positive feedback with M1 macrophages 1 suppresses epithelial ovarian cancer progression 2
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 780 views
Review
Accepted on 19 Dec 2025
Therapeutic vaccines targeting HPV epitopes in human Papillomavirus – positive oropharyngeal cancer: A critical review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 244 views
Study Protocol
Accepted on 19 Dec 2025
Personalized Neoantigen DC Vaccine Combined with Camrelizumab Following Definitive Therapy in Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (CHANT-241): Protocol for a Randomized Controlled Trial
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 196 views
Original Research
Accepted on 19 Dec 2025
Neoadjuvant Serplulimab and SOX Chemotherapy for Locally Advanced Gastric Cancer: Pathological Responses and Systemic Immune Signatures from a Phase II Trial
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 141 views
Mini Review
Accepted on 19 Dec 2025
Decoding Inflammatory Regulation in Ovarian Cancer at Single-Cell Resolution
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 244 views
Review
Accepted on 19 Dec 2025
The Neuro-Immune Axis in Cancer: Mechanisms of Innervation-Driven Tumor Progression and Therapeutic Opportunities
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 171 views
Original Research
Published on 19 Dec 2025
Anti-VEGF immunotherapy with HEBERSaVax suppresses melanoma growth and metastasis via angiogenesis blockade and enhanced T-cell infiltration
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1667651
- 760 views
Review
Published on 19 Dec 2025
Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1664587
- 903 views
Original Research
Published on 19 Dec 2025
LST1: a novel biomarker for efferocytosis in the co-occurrence of type 2 diabetes mellitus and clear cell renal cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1737749
- 744 views
Review
Published on 19 Dec 2025
The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1735873
- 1,038 views
Original Research
Published on 19 Dec 2025
SAA restricts T cell mediated anti-tumor immunity by limiting antigen presentation in lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1735479
- 692 views
Mini Review
Published on 19 Dec 2025
The dual role of glucocorticoids in the breast cancer immune microenvironment: mechanisms and therapeutic implications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1719277
- 683 views
Original Research
Published on 19 Dec 2025
Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small cell lung cancer: a multicenter study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1686260
- 678 views